Net Income (Loss) Attributable to Parent in USD of International Stem Cell CORP from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
International Stem Cell CORP quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • International Stem Cell CORP Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $57K.
  • International Stem Cell CORP Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$59K, a 91.3% increase year-over-year.
  • International Stem Cell CORP annual Net Income (Loss) Attributable to Parent for 2024 was -$209K, a 59.5% decline from 2023.
  • International Stem Cell CORP annual Net Income (Loss) Attributable to Parent for 2023 was -$131K, a 60.4% increase from 2022.
  • International Stem Cell CORP annual Net Income (Loss) Attributable to Parent for 2022 was -$331K, a 63.2% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

International Stem Cell CORP Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$59K $57K +$182K 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 -$241K $129K +$10K +8.4% 01 Apr 2025 30 Jun 2025 10-Q 13 Nov 2025
Q1 2025 -$251K -$256K -$42K -19.6% 01 Jan 2025 31 Mar 2025 10-Q 13 Nov 2025
Q4 2024 -$209K $11K +$469K 01 Oct 2024 31 Dec 2024 10-K 28 Mar 2025
Q3 2024 -$678K -$125K +$6K +4.58% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$684K $119K -$373K -75.8% 01 Apr 2024 30 Jun 2024 10-Q 13 Nov 2025
Q1 2024 -$311K -$214K -$180K -529% 01 Jan 2024 31 Mar 2024 10-Q 13 Nov 2025
Q4 2023 -$131K -$458K -$481K -2091% 01 Oct 2023 31 Dec 2023 10-K 28 Mar 2025
Q3 2023 $350K -$131K +$212K +61.8% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $138K $492K +$494K 01 Apr 2023 30 Jun 2023 10-Q 13 Nov 2024
Q1 2023 -$356K -$34K -$25K -278% 01 Jan 2023 31 Mar 2023 10-Q 13 Nov 2024
Q4 2022 -$331K $23K +$374K 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 -$705K -$343K -$178K -108% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$527K -$2K* -$218K 01 Apr 2022 30 Jun 2022 10-Q 13 Nov 2023
Q1 2022 -$309K -$9K +$590K +98.5% 01 Jan 2022 31 Mar 2022 10-Q 13 Nov 2023
Q4 2021 -$899K -$351K +$370K +51.3% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 -$1.27M -$165K +$379K +69.7% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q2 2021 -$1.65M $216K +$1.3M 01 Apr 2021 30 Jun 2021 10-Q 14 Nov 2022
Q1 2021 -$2.95M -$599K -$226K -60.6% 01 Jan 2021 31 Mar 2021 10-Q 14 Nov 2022
Q4 2020 -$2.72M -$721K +$1.99M +73.4% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 -$4.72M -$544K -$547K -18233% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 -$4.17M -$1.09M -$438K -67.6% 01 Apr 2020 30 Jun 2020 10-Q 12 Nov 2021
Q1 2020 -$3.73M -$373K +$533K +58.8% 01 Jan 2020 31 Mar 2020 10-Q 12 Nov 2021
Q4 2019 -$4.27M -$2.71M -$1.69M -164% 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 -$2.58M $3K -$118K -97.5% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 -$2.46M -$648K -$254K -64.5% 01 Apr 2019 30 Jun 2019 10-Q 12 Nov 2020
Q1 2019 -$2.21M -$906K -$76K -9.16% 01 Jan 2019 31 Mar 2019 10-Q 12 Nov 2020
Q4 2018 -$2.13M -$1.03M +$361K +26% 01 Oct 2018 31 Dec 2018 10-K 01 Jun 2020
Q3 2018 -$2.49M $121K +$2.29M 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 -$4.78M -$394K -$962K -169% 01 Apr 2018 30 Jun 2018 10-Q 12 Nov 2019
Q1 2018 -$3.82M -$830K +$2.25M +73.1% 01 Jan 2018 31 Mar 2018 10-Q 12 Nov 2019
Q4 2017 -$6.07M -$1.39M -$3.55M -164% 01 Oct 2017 31 Dec 2017 10-K 15 Apr 2019
Q3 2017 -$2.52M -$2.16M -$2.58M -623% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $59K $568K -$10.4M -94.8% 01 Apr 2017 30 Jun 2017 10-Q 14 Aug 2018
Q1 2017 $10.4M -$3.08M +$11.5M +78.8% 01 Jan 2017 31 Mar 2017 10-Q 21 May 2018
Q4 2016 -$1.08M $2.16M +$3.69M 01 Oct 2016 31 Dec 2016 10-K 09 Apr 2018
Q3 2016 -$4.77M $414K +$953K 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017
Q2 2016 -$5.73M $10.9M +$10.2M +1410% 01 Apr 2016 30 Jun 2016 10-Q 11 Aug 2017
Q1 2016 -$15.9M -$14.6M -$13.3M -1032% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017
Q4 2015 -$2.64M -$1.53M +$3.07M +66.7% 01 Oct 2015 31 Dec 2015 10-K 31 Mar 2017
Q3 2015 -$5.7M -$539K +$1.5M +73.5% 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 -$7.2M $723K +$5.13M 01 Apr 2015 30 Jun 2015 10-Q 15 Aug 2016
Q1 2015 -$12.3M -$1.29M +$148K +10.3% 01 Jan 2015 31 Mar 2015 10-Q 16 May 2016
Q4 2014 -$12.5M -$4.6M -$1.83M -66.1% 01 Oct 2014 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 -$10.6M -$2.03M +$1.77M +46.5% 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 -$12.4M -$4.41M -$2.21M -100% 01 Apr 2014 30 Jun 2014 10-Q 13 Aug 2015
Q1 2014 -$10.2M -$1.44M +$277K +16.2% 01 Jan 2014 31 Mar 2014 10-Q 11 May 2015
Q4 2013 -$10.5M -$2.77M -$170K -6.54% 01 Oct 2013 31 Dec 2013 10-K 30 Mar 2015
Q3 2013 -$10.3M -$3.8M -$1.72M -82.6% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 -$8.59M -$2.2M +$277K +11.2% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 -$8.87M -$1.71M +$965K +36% 01 Jan 2013 31 Mar 2013 10-Q 13 May 2014
Q4 2012 -$9.83M -$2.6M +$24K +0.92% 01 Oct 2012 31 Dec 2012 10-K 17 Mar 2014
Q3 2012 -$9.86M -$2.08M +$484K +18.9% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013
Q2 2012 -$10.3M -$2.48M -$88K -3.68% 01 Apr 2012 30 Jun 2012 10-Q 08 Aug 2013
Q1 2012 -$10.3M -$2.68M -$1.08M -67.8% 01 Jan 2012 31 Mar 2012 10-Q 14 May 2013
Q4 2011 -$9.17M -$2.62M 01 Oct 2011 31 Dec 2011 10-Q 13 Nov 2013
Q3 2011 -$2.57M +$454K +15% 01 Jul 2011 30 Sep 2011 10-Q 08 Nov 2012
Q2 2011 -$2.39M -$6.62M -157% 01 Apr 2011 30 Jun 2011 10-Q 08 Aug 2012
Q1 2011 -$1.6M 01 Jan 2011 31 Mar 2011 10-Q 14 May 2012
Q3 2010 -$3.02M 01 Jul 2010 30 Sep 2010 10-Q 14 Nov 2011
Q2 2010 $4.23M 01 Apr 2010 30 Jun 2010 10-Q 15 Aug 2011

International Stem Cell CORP Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$209K -$78K -59.5% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025
2023 -$131K +$200K +60.4% 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025
2022 -$331K +$568K +63.2% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024
2021 -$899K +$1.83M +67% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023
2020 -$2.72M +$1.54M +36.1% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 -$4.27M -$2.13M -100% 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
2018 -$2.13M +$3.94M +64.9% 01 Jan 2018 31 Dec 2018 10-K 01 Jun 2020
2017 -$6.07M -$4.99M -462% 01 Jan 2017 31 Dec 2017 10-K 15 Apr 2019
2016 -$1.08M +$1.56M +59.1% 01 Jan 2016 31 Dec 2016 10-K 09 Apr 2018
2015 -$2.64M +$9.84M +78.9% 01 Jan 2015 31 Dec 2015 10-K 31 Mar 2017
2014 -$12.5M -$2M -19.1% 01 Jan 2014 31 Dec 2014 10-K 30 Mar 2016
2013 -$10.5M -$646K -6.57% 01 Jan 2013 31 Dec 2013 10-K 30 Mar 2015
2012 -$9.83M -$662K -7.22% 01 Jan 2012 31 Dec 2012 10-K 17 Mar 2014
2011 -$9.17M +$3.55M +27.9% 01 Jan 2011 31 Dec 2011 10-Q 13 Nov 2013
2010 -$12.7M 01 Jan 2010 31 Dec 2010 10-Q 13 Nov 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.